XEDGE Trademark

Trademark Overview


On Monday, August 26, 2019, a trademark application was filed for XEDGE with the United States Patent and Trademark Office. The USPTO has given the XEDGE trademark a serial number of 88592310. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 27, 2021. This trademark is owned by Pfizer Inc.. The XEDGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
xedge

General Information


Serial Number88592310
Word MarkXEDGE
Filing DateMonday, August 26, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, September 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021EXTENSION 2 GRANTED
Friday, January 8, 2021EXTENSION 2 FILED
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Thursday, June 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2020EXTENSION 1 GRANTED
Tuesday, June 23, 2020EXTENSION 1 FILED
Tuesday, June 23, 2020TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Monday, September 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 29, 2019NEW APPLICATION ENTERED IN TRAM